Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]
返回论文页
|更新时间:2023-05-16
|
Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]
Genes & DiseasesVol. 10, Issue 2, (2023)
作者机构:
1. School of Laboratory Medicine, Chongqing Medical University,Chongqing,China,400016
2. Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400042
Chunmei Yang, Lulu Zhang, Huakun Huang, et al. Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]. [J]. Genes & Diseases 10(2).(2023)
DOI:
Chunmei Yang, Lulu Zhang, Huakun Huang, et al. Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]. [J]. Genes & Diseases 10(2).(2023) DOI: 10.1016/j.gendis.2023.02.002.
Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]